Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - WEST PHARMACEUTICAL SERVICES INC | ex322cfo906certification_2.htm |
| EX-31.1 - EX-31.1 - WEST PHARMACEUTICAL SERVICES INC | ex311ceo302certification_2.htm |
| EX-32.1 - EX-32.1 - WEST PHARMACEUTICAL SERVICES INC | ex321ceo906certification_2.htm |
| EX-31.2 - EX-31.2 - WEST PHARMACEUTICAL SERVICES INC | ex312cfo302certification_2.htm |
| EX-21 - EX-21 - WEST PHARMACEUTICAL SERVICES INC | ex21listofsubsidiaries_2020.htm |
| EX-4.4 - EX-4.4 - WEST PHARMACEUTICAL SERVICES INC | ex44descriptionofregistere.htm |
| 10-K - 10-K - WEST PHARMACEUTICAL SERVICES INC | wst-20201231.htm |
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-133863 and 333-145186) and Form S-8 (No. 333-106977, 333-143129, 333-156492, 333-171453, 333-174153 and 333-211088) of West Pharmaceutical Services, Inc. of our report dated February 23, 2021 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 23, 2021